(Q41926882)

English

Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study

scientific article published on February 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Plasmodium falciparum

0 references

0 references

Plasmodium falciparum malaria

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Peter C. Gøtzsche

3

object named as

P C Gøtzsche

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

author name string

A M Rønn

1

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

J Rønne-Rasmussen

2

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

publication date

1 February 1998

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Tropical Medicine and International Health

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

83-88

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Double-blind studies with mefloquine alone and in combination with sulfadoxine-pyrimethamine in 120 adults and 120 children with falciparum malaria in Vietnam

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Mefloquine for multidrug-resistant malaria

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Post-malaria neurological syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Encephalopathy and memory disorders during treatments with mefloquine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Neurologic reactions after a therapeutic dose of mefloquine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

CNS adverse events associated with antimalarial agents. Fact or fiction?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Immune activation during cerebellar dysfunction following Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Neuropsychiatric side effects of mefloquine in Africans

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Central anticholinergic syndrome with the antimalarial drug mefloquine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Acute psychosis after mefloquine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1998.00163.X

21 January 2018

Identifiers

10.1046/J.1365-3156.1998.00163.X

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41926882&oldid=1929947364"